Market Highlights According to MRFR analysis, Uveitis Treatment Market is expected to register a CAGR of 5.6% during the forecast period of 2019 to 2025 and was valued at USD 534.6 million in 2018. Uveitis is an inflammation that occurs in the uvea. It is found in people aged between 20 to 50. Based on the origin of inflammation, uveitis categories in major three types, namely, anterior uveitis, posterior uveitis, and intermediate uveitis. The growth of the global uveitis treatment market is determined by numerous factors such as increasing research & development (R&D) expenditure, rising prevalence of uveitis and continuous product launches. However, side-effect related to corticosteroid drugs is projected to restrain the growth of the market during the forecast period. The global uveitis treatment market is currently dominated by several market players. The key players are involved in expansion, product launches, and strategic collaborations to strengthen their market positions. Segmentation The global Uveitis Treatment Market Size has been segmented based on type, drug class, and end-user. The market, based on type, has been divided into anterior uveitis, intermediate uveitis, posterior uveitis, and others. The anterior uveitis is likely to hold maximum market share in the global uveitis treatment market. The global uveitis treatment market based on drug class has been segregated into corticosteroid drugs, anti-inflammatory drugs, immunosuppressive drugs, and others. The corticosteroids drugs segment is anticipated to hold the largest share in the market due to the rising preference in the treatment of uveitis. The end-user segments of the market are hospitals, specialty clinics, and others. The hospital's segment is expected to hold the largest share of the market, as these are the primary locations where patients receive treatment. Key Players Some of the key players in the Global Uveitis Treatment Market are Allergan PLC, Novartis AG, Bausch Health, EyePoint Pharmaceuticals, Inc., AbbVie Inc., Horizon Therapeutics PLC, Mylan N.V., and Alimera Sciences. Browse Full Report Details @ https://www.marketresearchfuture.com/reports/uveitis-treatment-market-8457 Regional Analysis The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas are anticipated to hold the largest market share owing to the increasing prevalence of uveitis, the presence of a well-established healthcare sector, and high R&D expenditures. The uveitis treatment market in the Americas has further been branched into North America and Latin America, with the North American market divided into the US and Canada. The European uveitis treatment market has been categorized as Western Europe and Eastern Europe. The Western European market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The uveitis treatment market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. Due to the presence of a large patient pool and expansion of healthcare facilities, the market in Asia-Pacific is expected to be the fastest-growing. The uveitis treatment market in the Middle East & Africa has been divided into the Middle East and Africa. More Healthcare Industry Related Reports Orthopedic Braces Market Research Report - Global Forecast till 2025 Clinical Trials Market Research Report - Forecast to 2023 Digital Diabetes Management Market Research Report – Global Forecast till 2023 About Market Research Future: At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
0 Comments
Artificial Intelligence in Drug Discovery Market, Trends, Size, Competitive Landscape 20275/28/2021 Endovascular Aneurysm Repair Devices Market Demand, Trends, Size, Competitive Landscape 20275/28/2021 Market Scenario
Global endovascular aneurysm repair devices market is likely to grow significantly over the forecast period. It is estimated that the global endovascular aneurysm repair devices market is expected to record a CAGR ~ 6.4 % during the forecast period of 2018 to 2023. The weakening and bulging of the aorta is called aortic aneurysm. The bulging can cause a leak that spills blood into the body. It can direct the blood flow away from the organs and tissues, causing severe complications, such as kidney damage, heart attacks, stroke, and even death. Thus, endovascular repair can be done by placing a stent-graft in an aneurysm through a small hole in the blood vessels in the groin area. Numerous factors such as reduced recovery times, low-cost hospitalization charges, and technological advancements in repair devices are expected to drive the growth of the market. For instance, in March 2017, Terumo Corporation completed the acquisition of Bolton Medical, Inc. with the acquired company being a leading innovator in thoracic and abdominal stent graft systems, Terumo Corporation aimed to strengthen its growth in vascular graft segment The global endovascular aneurysm repair devices market is currently dominated by many market players. The key players in the market are engaged in new product launches and strategic collaborations to strengthen its market position. For instance, in April 2018, Vascutek Ltd. and Bolton Medical, subsidiaries of Terumo Corporation, have merged into Terumo Aortic. Combining the aortic companies into a single business, Terumo Corporation aims to grow its presence in the aortic and vascular implants market. It is estimated that the global endovascular aneurysm repair devices market is expected to record a CAGR ~ 6.4 % during the forecast period of 2018 to 2023. also read @ https://www.marketwatch.com/press-release/endovascular-aneurysm-repair-devices-market-2021-revenue-latest-trends-shares-comprehensive-analysis-and-forecasts-till-2023-2021-01-17 Key players
Endovascular Aneurysm Repair Devices Market Demand has been segmented into indication, site, anatomy, and products. The market, on the basis of indication, has been segmented into the abdominal aortic aneurysm, thoracic aortic aneurysm and others. The market, based on thoracic aortic aneurysm, has been further segmented into ascending aortic aneurysm, descending aortic aneurysm, thoracoabdominal aortic aneurysm, and thoracic arch aortic aneurysm. The market, on the basis of the site, has been segmented into infrarenal and pararenal. The market, based on pararenal site, has been sub-segmented into juxtarenal and suprarenal. The market, on the basis of anatomy, has been segmented into traditional and complex. The market, on the basis of products, has been segmented into percutaneous EVAR, fenestrated EVAR, aortic stents and TAA grafts, and others. Browse Complete 100 Pages Premium Research Report Enabled with 110 Respective Tables and Figures @ https://www.marketresearchfuture.com/reports/endovascular-aneurysm-repair-devices-market-6485 Related Reports More Healthcare Industry Related Reports Orthopedic Braces Market Research Report - Global Forecast till 2025 Clinical Trials Market Research Report - Forecast to 2023 Digital Diabetes Management Market Research Report – Global Forecast till 2023 About US: Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. Sinus Dilation Devices Market Size Dynamics and Global Industry Insights, Forecast to 20275/28/2021 Autoimmune Disease Diagnostics Market Segmentation
The Market Research Future Report provides an inclusive segmental analysis of the global autoimmune disease diagnostics market based on end user, test type, and disease type. By disease type, the autoimmune disease diagnostics market is segmented into localized autoimmune disease and systematic autoimmune disease. Systematic autoimmune disease is again segmented into systematic lupus erythematosus (SLE), rheumatoid arthritis, multiple sclerosis, psoriasis, and others. Localized autoimmune diseases are again segmented into type 1 diabetes, thyroid, inflammatory bowel disease, and others. By test type, the autoimmune disease diagnostics market is segmented into agglutination, multiplex immunoassay, immunofluorescence assays (IFA), line blot, counter immune-electrophoresis, dot blot, double immune diffusion, enzyme-linked immunosorbent assay (ELISA), western blotting, and others. By end user, the autoimmune disease diagnostics market is segmented into research laboratories, diagnostic centers, hospitals, and others. also read @ https://www.medgadget.com/2020/11/autoimmune-disease-diagnostics-market-size-estimation-growth-projection-sales-insights-future-trends-global-industry-overview-and-covid-19-impact-analysis-by-2023.html Autoimmune Disease Diagnostics Market - Highlights Autoimmune disease is a disorder where body’s own immune system starts attacking the healthy cells instead of foreign particles and disease-causing agents. The rising awareness about autoimmune disorders, technological advancement in the healthcare sector and rise in number of cases of autoimmune diseases are the factors driving the growth of the global autoimmune disease diagnostics market. Moreover, strategic collaborations and aggressive strategies by major players are also contributing to the growth of the market. For instance, in May 2018, Myriad Genetics, Inc. has acquired Counsyl, Inc. for USD 375 million, Counsyl is a global leader in genetic testing and personalized medicine segment. The rising cases of false positive result of autoimmune disorders, scarcity of technicians, and price war between companies are likely to hinder Autoimmune Disease Diagnostics Market Size during the forecast period Autoimmune Disease Diagnostics Market Regional Analysis By region, the global autoimmune disease diagnostics market covers the growth opportunities and recent trends across Europe, the Americas, the Asia Pacific (APAC), and the Middle East and Africa (MEA). Of these, the Americas will have the lions share in the market over the forecast period. Factors propelling the autoimmune disease diagnostics market growth in the region include the adoption of advanced technology, rising financial support from the government as well as private organizations, and rising incidence of various autoimmune diseases, especially rheumatoid arthritis. The global autoimmune disease diagnostics market in Europe is predicted to hold the second-largest share over the forecast period for aggressive strategies adopted by leading industrial players, growing healthcare industry, and rising automation in laboratories. The autoimmune disease diagnostics market in the APAC region is predicted to grow at a fast pace over the forecast period. Factors propelling the autoimmune disease diagnostics market growth in the region include rising private-public partnerships to improve the healthcare sector, increasing incidence of autoimmune disorders, and rising population. Browse More Details at: https://www.marketresearchfuture.com/reports/autoimmune-disease-diagnostics-market-6715 The autoimmune disease diagnostics market in the MEA is predicted to have a small share during the forecast period for poor medical facilities, lack of technical knowledge, and an underdeveloped healthcare sector. Autoimmune Disease Diagnostics Market Key Players Leading players profiled in the global autoimmune disease diagnostics market report include Trinity Biotech Plc., Hemagen Diagnostics, Inc., Myriad Genetics, Inc., F. Hoffmann-la Roche, Inc., EUROIMMUN AG, AstraZeneca, Bio-rad Laboratories, Inova Diagnostics, Siemens Healthcare Private Limited, Beckman Coulter, Inc., BioMérieux SA, and Thermo Fisher Scientific. Browse More Related Reports at: Orthopedic Braces Market Research Report - Global Forecast till 2027 Clinical Trials Market Research Report - Forecast to 2027 Digital Diabetes Management Market Research Report – Global Forecast till 2027 NOTE: Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details. About Market Research Future: At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. Digital Diabetes Management Market Size, Business Opportunities, COVID-19 Impact, Sales Growth 20275/28/2021 Market Highlights
The digital diabetes management provide a platform that simplify the tracking of diabetes data. It helps Type 1 and Type 2 diabetes patients to manage blood test results from a glucose meter, records of actual insulin delivery, statistical evaluation. The increasing prevalence of diabetes, technological advancements, rising demand for selfcare, and involvement of major players in product launch, collaboration, and strategic merger & acquisitions are the major factors driving the growth of the global digital diabetes management market. Additionally, increasing research and development spending by the top players are fueling the growth of the market during forecast period. For instance, in 2017, Medtronic introduce MiniMed 670G first hybrid closed loop system for type 1 diabetes patients. Also, in 2018, Roche Diagnostics and Wellthy Therapeutics Private Limited (India) signed a partnership for offering an artificial intelligence-based digital diabetes coaching solution for users of the Accu-Chek Active system. However, the high cost associated with homecare devices and lack of awareness may hamper the growth of the market during the assessment period. also read @ https://www.medgadget.com/2019/11/digital-diabetes-management-market-analysis-comprehensive-research-study-size-share-global-leading-growth-drivers-potential-growth-industry-trends-till-2023.html Digital Diabetes Management Market Segmentation The global digital diabetes management market has been segmented by type, product and services, and end user. By type, the market is divided into wearable devices and handheld devices. The wearable devices segment is expected to hold the largest Digital Diabetes Management Market Size during the forecast period owing to regulatory approval of advanced products and technological advancements such as smart insulin patches. By product and service, the global digital diabetes management market is segmented into digital diabetes management apps, data management software and platforms, devices, and services. Devices consist of smart insulin pumps/closed loop systems & smart insulin patches, smart glucose meters, smart insulin pens, and continuous glucose monitoring systems. Moreover, digital diabetes management apps have been sub-segmented into weight & diet management apps and diabetes & blood glucose tracking apps. End users of the digital diabetes management market include homecare, academic & research institutes, hospitals & specialty diabetes clinics, and others. The homecare segment can hold the largest market share in the global digital diabetes management market during the forecast period. Digital Diabetes Management Market Regional Analysis By region, the global digital diabetes management market is segmented into the Americas, Europe, Asia Pacific (APAC), and the Middle East & Africa (MEA). The Americas are touted to lead the global digital diabetes management market till the end of the forecast period owing to acceptance of digitally advanced solutions, favorable government schemes, and initiatives for promoting public health. Awareness of diabetes and development of mobile applications can drive regional market demand. The regional growth is characterized by mergers, acquisitions, and novel product launches. For instance, Abbott and Dexcom have decided to join hands with Insulet for the development of a digital health platform. Europe is the second-largest region of the digital diabetes management market and headed for growth due to ample funds in research and development and government support. Raising of funds by companies for encouraging research is expected to drive regional growth. Recently, Oviva a Swiss-based provider of digital solutions for diabetes has raised close to USD 21 million in funding. Browse More Details at: https://www.marketresearchfuture.com/reports/digital-diabetes-management-market-7527 Digital Diabetes Management Market Competitive Outlook Tandem Diabetes Care, Inc., Glooko, Inc., Agamatrix, Inc., Insulet Corporation, Ascensia Diabetes Care Holdings Ag., B. Braun Melsungen AG, Medtronic PLC, F. Hoffmann-La Roche, Dariohealth Corporation, Dexcom, Inc., Abbott Laboratories, Tidepool, Lifescan, Inc., and others are major players of the global digital diabetes management market. Browse More Related Research Reports at: Endovascular Aneurysm Repair Devices Market Research Report – Forecast to 2023 Sinus Dilation Devices Market Report-Global Forecast till 2023 Autoimmune Disease Diagnostics Market Research Report - Global Forecast till 2023 NOTE: Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details. About Market Research Future: At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. Market Synopsis of the Global Medical Device Connectivity Market
Global medical device connectivity market is expected to grow at an approximate CAGR of 16.1% during the forecast period, 2018–2023. Moreover, the increasing penetration of Electronic Health Records (EHRs) and health information exchange systems in healthcare organizations, are the factors responsible for the market growth. Major factors responsible for the market growth are penetration of EHRs through the collaboration between IT service providers and healthcare service providers also read @ https://www.openpr.com/news/1119530/medical-device-connectivity-market-2023-global-key-players-are-qualcomm-cerner-ge-healthcare-koninklijke-philips-n-v-bernoulli-enterprise-medtronic-cisco-systems-nanthealth-infosys-lantronix-true-process-ihealth-lab-and-more.html Medical Device Connectivity Market Competitive Leaderboard: Leading players in the global medical device connectivity market include eDevice Inc., Stryker Corporation, Nuvon Inc., iHealth Lab Inc., True Process, Lantronix, Infosys, Nanthealth, Cisco Systems, Medtronic, Bernoulli Enterprise, Koninklijke Philips NV, GE Healthcare, Cerner, and Qualcomm. In 2016, Allscripts Technologies signed a ten-year strategic agreement with Optumcare to deploy Allscripts TouchWork suite as its exclusive electronic health record (EHR) and practice management (PM) solution for physicians. The strategic agreement will provide physicians with the clinical, health plan, and analytical data, which will further enhance the high-quality care they provide to their patients. Moreover, in 2016, Cerner and Sharp Healthcare came together to extend the former’s electronic health record (EHR) system to the Sharp Community Medical Group. Through the expanded relationship with Cerner, Sharp will utilize an integrated platform to create consistencies by streamlining physician workflows and care team communications for transitions of care. All such instances are expected to boost the medical device connectivity market. Medical Device Connectivity Market Segmentation: The global medical device connectivity market is segmented on the basis of products and services, technology, end user, and region. By products and services, the market is segmented into medical device connectivity solutions and medical device connectivity services. Medical device connectivity solutions are further segmented into medical device integration solutions, telemetry systems, connectivity hubs, and interface devices. Whereas, medical device connectivity services are further segmented into support and maintenance services, implementation and integration services, and training services. Based on technology the market is segmented into wired technologies, wireless technologies, and hybrid technologies. Wireless technologies are likely to grow at a rapid growth rate over the forecast period. By end user, the market is segmented into hospitals, home healthcare, ambulatory care centers, diagnostic centers, and others. Hospitals account for the largest share in the global medical device connectivity market. Medical Device Connectivity Market Regional Analysis: North America accounts for the global Global Medical Device Connectivity Market, followed by Europe. Asia Pacific is also expected to be an important regional market over the forecast period. Obtain Premium Research Report Details, Considering the impact of COVID-19 @ https://www.marketresearchfuture.com/reports/medical-device-connectivity-market-6041 Related Reports Tetanus Toxoid Vaccine Market Research Report- Global Forecast till 2027 Antifungal Treatment Market Research Report- Global Forecast till 2027 Human Rotavirus Vaccine Market Research Report- Forecast to 2027 About Market Research Future: MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members. |
AuthorWrite something about yourself. No need to be fancy, just an overview. Archives
October 2021
Categories |